Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2003
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma
07/03/2003US20030124063 Premeasured single unit dose; may be free of anti-microbial preservatives, such as benzalkonium chloride.
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470813A1 1,4-dihydro-1,4-diphenylpyridine derivatives
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470442A1 Method and compositions for treating respiratory pathologies
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2469884A1 7-amino-benzothiazole derivatives as adenosine receptor ligands
07/03/2003CA2469372A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2468083A1 Use of heterocyclic carboxamides to treat anemia
07/02/2003EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323419A1 Airway mucus secretion inhibitors
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322762A2 Haemophilus influenzae antigens and corresponding dna fragments
07/02/2003EP1322760A2 G-protein coupled receptors
07/02/2003EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
07/02/2003EP1322673A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/02/2003EP1322656A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
07/02/2003EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322611A1 Chemical compounds
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322321A2 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
07/02/2003EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322301A1 Combination particles for the treatment of asthma
07/02/2003EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients
07/02/2003EP1322175A2 Food supplement
07/02/2003EP1224180B1 Substituted azoles
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP1210346B1 New active marine alkaloids
07/02/2003EP1059921B1 Use of macrolide compounds for the treatment of acute lung injury
07/02/2003EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity
07/02/2003EP1041966B1 Pharmaceutical compositions comprising zafirlukast
07/02/2003EP0954292B1 Pharmaceutical formulations with delayed drug release
07/02/2003CN1427719A Use of substituted acryloyl distamycin derivatives in treatment of tumors associated with high levels of glutathione
07/02/2003CN1427718A Pharmaceutical compounds for treating COPD
07/02/2003CN1426792A Formulation of throat clearing and moistening tablet
07/02/2003CN1426791A Formulation of throat clearing and moistening distillate medicinal water
07/02/2003CN1426789A Sterculia frost flower lozenge and its preparation method
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/02/2003CN1113057C Quinoline derivatives
07/01/2003US6586474 Amidino compounds useful as nitric oxide synthase inhibitors
07/01/2003US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
07/01/2003US6586446 Chemotaxic cytokine agonists or antagonists such as N(3-acetylphlenyl)-N'-(-2-((-3-((4-fluorophenyl)methyl)-8 -azabicyclo(3.2.1)oct-8-yl)methyl)-(2R)-1-cyclohexyl)urea, used as antiinflammatory agents for asthma or allergies
07/01/2003US6586441 Adenosine receptor ligands and their use in the treatment of disease
07/01/2003US6586432 Neurokinin-1 receptor antagonists
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
07/01/2003US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders
07/01/2003US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes
07/01/2003US6586008 For delivery to the pulmonary system; particles consist of a therapeutic, prophylactic or diagnostic agent, or any combination thereof, an amino acid or salt thereof, and a phospholipid or combination of phospholipids
07/01/2003US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level
07/01/2003US6585981 The Mycoplasma hyopneumoniae grows at 34 degrees C. but does not grow at 38.5 - 39.5 degrees C.
07/01/2003US6585959 Excipient having different particle size distribution are added in alternate layers into a suitable mixing vessel; mixing together using a suitable mixer, wherein a portion of the excipient having the larger particle size is added first
07/01/2003US6585958 Medicinal aerosol formulations
06/2003
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof
06/26/2003WO2003051884A1 Fused indole compound, process for producing the same, and use
06/26/2003WO2003051878A1 Quinolinones as prostaglandin receptor ligands
06/26/2003WO2003051876A1 Pyrazolopyridine derivatives and medicinal use thereof
06/26/2003WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
06/26/2003WO2003051870A1 Novel compounds
06/26/2003WO2003051868A1 Lactams as tachykinin antagonists
06/26/2003WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051828A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents
06/26/2003WO2003051393A2 Enzymatic cleavable reagents for specific delivery to disease sites
06/26/2003WO2003051392A2 Streptococcus pneumoniae vaccine
06/26/2003WO2003051388A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003WO2003051372A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003WO2003051346A2 Use of selective pde5 inhibitors for treating partial and global respiratory failure
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003030920A9 An antispasmodic agent spaced drug delivery system
06/26/2003WO2003026612A3 Dosage forms having an inner core and outer shell
1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 878